Skip to content
Unrated Drug recall · FDA · Published April 19, 2013

Qualitest Recalls Glimepiride 2mg Tablets Due to Oversized Tablet

Qualitest Pharmaceuticals is recalling one lot of Glimepiride 2mg tablets because an oversized tablet was found. Check your bottle's lot number.

🇺🇸 FDA recall #D-298-2013DrugQualitest Pharmaceuticals ›
Take action

Contact the company

Recalling firmQualitest Pharmaceuticals120 Vintage Dr NE · Huntsville, AL 35811-8216
✎ GovInfoNow plain-language explainer

Qualitest Pharmaceuticals has recalled a specific lot of Glimepiride Tablets USP, 2 mg, 100-count bottles due to quality control issues. An oversized tablet was discovered in one sealed bottle at the retail level. The recall affects 10,373 bottles distributed nationwide. Read more at govinfonow.com/recall/48029-qualitest-pharmaceuticals-recalls-glimepiride-tablets-usp-2-mg-100-count.

Source Summary by GovInfoNow · govinfonow.com/recall/48029-qualitest-pharmaceuticals-recalls-glimepiride-tablets-usp-2-mg-100-count · Updated October 13, 2026 · FDA enforcement record: FDA #D-298-2013

Cite this page

“Qualitest Recalls Glimepiride 2mg Tablets Due to Oversized Tablet.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/48029-qualitest-pharmaceuticals-recalls-glimepiride-tablets-usp-2-mg-100-count. Based on FDA recall #D-298-2013 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-298-2013%22&limit=1).

The FDA announced on April 19, 2013, that Qualitest Pharmaceuticals voluntarily recalled Glimepiride Tablets USP, 2 mg, due to failed tablet specifications involving an oversized tablet. Owners should contact the manufacturer for a refund.

How to tell if you have it

  • Brand: Qualitest Pharmaceuticals
  • Product: Glimepiride Tablets USP 2 mg
  • NDC: 0603-3745-21
  • Lot #: C0671212A
  • Expiration: 12/14
  • Quantity: 10,373 bottles

The hazard

The recall addresses failed tablet specifications after one oversized tablet was found in a sealed 100-count bottle of Glimepiride at the retail level.

Context

GovInfoNow's records show Qualitest Pharmaceuticals has had 12 other recalls since August 8, 2013. Other recent recalls of similar products include Golden State Medical Recalls Primidone Tablets Due to Contamination (April 27, 2026), Ajanta Pharma Fluphenazine Tablets Recall: Impurity Risk in 100-Count Bottles (August 25, 2026), and Wells Pharma Fentanyl Citrate Injectable Solution Recall: Cgmp Deviations (April 1, 2026).

How to tell if you have this one

Check your medication bottle for the brand Qualitest Pharmaceuticals, NDC 0603-3745-21, and Lot # C0671212A with an expiration date of 12/14. The product is a 100-count bottle of Glimepiride Tablets USP, 2 mg.

  • Brand
    Qualitest Pharmaceuticals
  • Category
    Drug

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 9 months after the firm started it.

1. Firm started the recall: Apr 19, 201312. FDA classified it Class II: Apr 25, 201323. Published in FDA’s Enforcement Report: May 1, 201334. FDA terminated the recall: Jan 13, 2014420132014
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-298-2013 (April 19, 2013) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-298-2013 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA